Integrative omics provide biological and clinical insights into acute respiratory distress syndrome

Mulong Du,Joe G. N. Garcia,Jason D. Christie,Junyi Xin,Guoshuai Cai,Nuala J. Meyer,Zhaozhong Zhu,Qianyu Yuan,Zhengdong Zhang,Li Su,Sipeng Shen,Xuesi Dong,Hui Li,John N. Hutchinson,Paula Tejera,Xihong Lin,Meilin Wang,Feng Chen,David C. Christiani
DOI: https://doi.org/10.1007/s00134-021-06410-5
IF: 38.9
2021-05-25
Intensive Care Medicine
Abstract:Acute respiratory distress syndrome (ARDS) is accompanied by a dysfunctional immune-inflammatory response following lung injury, including during coronavirus disease 2019 (COVID-19). Limited causal biomarkers exist for ARDS development. We sought to identify novel genetic susceptibility targets for ARDS to focus further investigation on their biological mechanism and therapeutic potential.
critical care medicine
What problem does this paper attempt to address?